Patel Dinesh V PH D

President and CEO, DirectorProtagonist Therapeutics, Inc (PTGX) · full profile →Form 4 · filed Aug 12, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$14.9M
Net Open-Market Flow
-$14.9M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 11, 2026Option exercise(M)34K$21.58$739K558K
Aug 11, 2026Sell(S)34K$148.52$5.1M523K
Aug 10, 2026Option exercise(M)66K$21.58$1.4M589K
Aug 10, 2026Sell(S)66K$149.11$9.8M523K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 11, 2026Option exercise(M)34K$0125K
Aug 10, 2026Option exercise(M)66K$0159K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-095111) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.